Early Predicts Later Weight Gain With Depot Medroxyprogesterone Acetate

2010 ◽  
Vol 102 (1) ◽  
pp. 70
Author(s):  
Gregory E. Gilbert ◽  
Amy H. Wahlquist
Contraception ◽  
2011 ◽  
Vol 84 (3) ◽  
pp. 305
Author(s):  
A. Bonny ◽  
S. Mesiano ◽  
B. Kaufman ◽  
M. O′Riordan ◽  
M. Reed ◽  
...  

Author(s):  
Priscilla de Nazaré Silva dos Santos ◽  
Waleska Oliveira Modesto ◽  
Nathalia Dal’Ava ◽  
Maria Valéria Bahamondes ◽  
Elizabeth João Pavin ◽  
...  

2020 ◽  
Vol 7 (2) ◽  
pp. 149
Author(s):  
Nurmainah Nurmainah ◽  
Sri Wahdaningsih ◽  
Syaazaratul Qamelia Innas

Kontrasepsi suntik merupakan salah satu kontrasepsi hormonal yang masih menjadi pilihan akseptor dalam mengatur kehamilan. Namun demikian, penggunaan kontrasepsi suntik Depot Medroxyprogesterone Acetate (DMPA) diketahui dapat meningkatkan berat badan selama pemakaian enam (6) bulan atau lebih. Tujuan penelitian ini dilakukan untuk menganalisis pengaruh penggunaan DMPA terhadap kenaikan berat badan akseptor. Penelitian ini merupakan penelitian observasional dengan rancangan penelitian potong lintang (cross sectional) yang bersifat analitik. Populasi dalam penelitian ini adalah seluruh akseptor baru suntik DMPA di Puskesmas Perumnas II Pontianak pada bulan Januari 2018 hingga Maret 2019. Variabel dari penelitian ialah usia, pekerjaan, paritas, dan kenaikan berat badan. Analisis dilakukan dengan menggunakan analisis paired t-test. Teknik pengambilan sampel yang digunakan ialah purposive sampling. Jumlah sampel yang memenuhi kriteria inklusi dan ekslusi sebanyak 81 akseptor. Dari hasil penelitian ini diperoleh bahwa sebagian besar akseptor berusia 20-35 tahun (71,6%), bekerja sebagai ibu rumah tangga (97,5%), mempunyai 2 anak atau lebih (77,8%), dan memiliki kenaikan berat badan 0-2 kg (44,4%). Berdasarkan hasil analisis paired t-test bahwa penggunaan suntik KB 3 bulan (DMPA) memiliki pengaruh terhadap kenaikan berat badan akseptor dengan nilai p=0,001. Kesimpulan dari penelitian ini bahwa terdapat pengaruh penggunaan DMPA terhadap kenaikan berat badan akseptor. Injectable contraception is a hormonal contraceptive used by acceptors in regulating pregnancy. However, the use of Depot Medroxyprogesterone Acetate (DMPA) is known to increase body weight after six months of use or more.. The purpose of this study was to analysis the effect of using DMPA on weight gain. This study was an observational study with cross sectional analytic study design. The population in this study were all new acceptors who used DMPA at the Perumnas II Pontianak Public Health Care in January 2018 to March 2019. Variables from the study were age, occupation, parity, and weight gain. Analysis was performed using paired t-test analysis. The sampling technique used was purposive sampling, where the number samples that met the inclusion and exclusion criteria were 81 acceptors. The results showed that most of the acceptors were aged 20-35 years (71,6%), work as housewives (97,5%), had 2 or more children (77,8%), and gained weight 0-2  kg (44,4%). Based on the results of paired t-test analysis, the use of DMPA has an effect on the acceptor’s weight gain with a value of p = 0.001. The conclusion of this study is that there is an effect of the use of DMPA on acceptor weight gain.Keywords: Acceptors, DMPA, weigt gain 


2015 ◽  
Vol 28 (3) ◽  
pp. 139-143 ◽  
Author(s):  
Hannah L.H. Lange ◽  
Martha A. Belury ◽  
Michelle Secic ◽  
Alicia Thomas ◽  
Andrea E. Bonny

2010 ◽  
Vol 23 (2) ◽  
pp. e69-e70
Author(s):  
Andrea E. Bonny ◽  
Sam Mesiano ◽  
Bram Kaufman ◽  
Mary Ann O'Riordan ◽  
Michael Reed ◽  
...  

Author(s):  
Irwan Daido ◽  
Andi M Tahir ◽  
St Maisuri T Chalid

Objective: To determine the comparison of body mass index (BMI) among acceptors of injectable depot medroxyprogesterone acetate (DMPA) with levonorgestrel implant acceptors for 1 year and comparison of lipid profiles between depot medroxyprogesterone acetate acceptors with levonorgestrel implants for 1 year. Method: This study was conducted at dr. Wahidin Sudirohusodo hospital, Makassar and its satellite hospitals as well as family planning social service cooperation between the National Family Planning Coordinating Board with the Department of Obstetrics and Gynecology Hasanuddin University. Result: The results showed the increase in BMI of levonorgestrel implant acceptors (1.25 kg/m2) was greater than DMPA acceptors (0.74 kg/m2). HDL cholesterol and triglycerides did not change significantly in either groups. LDL cholesterol was increased in DMPA acceptors (9.63 mg/dl) and decreased in implant acceptors (1.62 mg/dl). Total cholesterol increased in DMPA acceptors at 8.67 mg/dl) while in the levonorgestrel implant acceptors it was decreased by 5.37 mg/dl. Conclusion: Weight gain occured among acceptors of DMPA and implant however the weight gain is more profound among the implant acceptors. [Indones J Obstet Gynecol 2014; 3: 121-126] Keywords: body mass index, DMPA, levonorgestrel implant, lipid profile


Sign in / Sign up

Export Citation Format

Share Document